Trial Profile
A retrospective study comparing Inflammatory bowel disease related rate of hospitalisation and treatment discontinuation treated with Vedolizumab versus Infliximab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary) ; Infliximab
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 12 Dec 2016 New trial record